tiprankstipranks
Trending News
More News >
Amicus Therapeutics (FOLD)
:FOLD
US Market

Amicus (FOLD) Technical Analysis

Compare
1,011 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Amicus Therapeutics’s (FOLD) Moving Averages Convergence Divergence (MACD) indicator is -0.14, suggesting Amicus Therapeutics is a Sell.
Amicus Therapeutics’s (FOLD) 20-Day exponential moving average is 5.92, while Amicus Therapeutics’s (FOLD) share price is $5.95, making it a Buy.
Amicus Therapeutics’s (FOLD) 50-Day exponential moving average is 6.36, while Amicus Therapeutics’s (FOLD) share price is $5.95, making it a Sell.

Amicus (FOLD) Pivot Points

Jul 04, 2025, 04:16 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.34
5.50
5.67
5.83
6.00
6.16
6.33
Fibonacci
5.50
5.63
5.70
5.83
5.96
6.03
6.16
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Amicus (FOLD) Moving Averages

Jul 04, 2025, 04:16 PM
Period
Simple
Exponential
MA5
5.83Buy
5.84Buy
MA10
5.76Buy
5.84Buy
MA20
5.91Buy
5.92Buy
MA50
6.26Sell
6.36Sell
MA100
7.39Sell
7.17Sell
MA200
8.82Sell
8.51Sell
Amicus Therapeutics’s (FOLD) 10-Day exponential moving average is 5.84, while Amicus Therapeutics’s (FOLD) share price is $5.95, making it a Buy.
Amicus Therapeutics’s (FOLD) 100-Day exponential moving average is 7.17, while Amicus Therapeutics’s (FOLD) share price is $5.95, making it a Sell.
Amicus Therapeutics’s (FOLD) stock price is $5.95 and Amicus Therapeutics’s (FOLD) 50-day simple moving average is 6.26, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $5.95 and Amicus Therapeutics’s (FOLD) 100-day simple moving average is 7.39, creating a Sell signal.
Amicus Therapeutics’s (FOLD) stock price is $5.95 and Amicus Therapeutics’s (FOLD) 200-day simple moving average is 8.82, creating a Sell signal.

Amicus (FOLD) Technical Indicators

Jul 04, 2025, 04:16 PM
Name
Value
Implied Action
RSI (14)
48.42
Neutral
STOCH (9,6)
68.75
Neutral
STOCHRSI (14)
46.12
Neutral
MACD (12,26)
-0.14
Sell
ADX (14)
25.79
Neutral
Williams %R
-38.03
Buy
CCI (14)
-5.38
Neutral
ATR (14)
0.23
-
Ultimate Oscillator
55.23
Neutral
ROC
-3.09
Sell
Amicus Therapeutics’s (FOLD) Relative Strength Index (RSI) is 48.42, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Trend Strength Indicator (ADX) is 25.79, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Commodity Channel Index (CCI) is -5.38, creating a Neutral signal.
Amicus Therapeutics’s (FOLD) Price Rate of Change (ROC) is -3.09, creating a Sell signal.

FAQ

Is FOLD a Buy, Hold, or Sell?
Based on FOLD’s technical indicators, FOLD is a Hold.
    What is FOLD’s RSI (14)?
    FOLD’s RSI (14) is 48.42, which suggests FOLD is a Neutral.
      What is FOLD’s MACD?
      FOLD’s MACD is -0.14, which suggests FOLD is a Sell.
        What is FOLD’s 5-day moving average?
        FOLD’s 5-day moving average is 5.83, which suggests FOLD is a Buy.
          What is FOLD’s 20-day moving average?
          FOLD 20-day moving average is 5.91, which suggests FOLD is a Buy.
            What is FOLD’s 50-day moving average?
            FOLD’s 50-day moving average is 6.26, which suggests FOLD is a Sell.
              What is FOLD’s 200-day moving average?
              FOLD’s 200-day moving average is 8.82, which suggests FOLD is a Sell.
                What is FOLD’s Williams % R (14)?
                FOLD’s Williams % R (14) is -38.03, which suggests FOLD is a Buy.
                  What is FOLD’s CCI (14)?
                  FOLD’s CCI (14) is -5.38, which suggests FOLD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis